Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report) was up 3% during mid-day trading on Friday . The company traded as high as $5.58 and last traded at $5.45. Approximately 8,939 shares changed hands during trading, an increase of 313% from the average daily volume of 2,165 shares. The stock had previously closed at $5.29.
Graybug Vision Price Performance
The stock has a market capitalization of $8.56 million, a price-to-earnings ratio of -0.22 and a beta of 1.20. The business’s fifty day moving average price is $4.30 and its 200-day moving average price is $3.83.
About Graybug Vision
Graybug Vision, Inc, a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema.
Featured Articles
- Five stocks we like better than Graybug Vision
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Stocks Leading the U.S. Agriculture Comeback
- How Investors Can Find the Best Cheap Dividend Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
